Leukemia patients who failed drug-free remission get another shot with asciminib combo
Disease control
Recruiting now
This study tests whether adding asciminib to standard tyrosine kinase inhibitors (TKIs) can help people with chronic myeloid leukemia (CML) stop all medication and stay in remission. It includes 69 adults who have been on TKIs for at least 5 years but failed previous attempts to …
Phase: PHASE2 • Sponsor: Korean Society of Hematology • Aim: Disease control
Last updated May 01, 2026 15:57 UTC